Chalcone-imidazolone Compounds Induce Apoptosis in Breast Cancer Cells
Author Information
Author(s): Ramaiah M Janaki, Pushpavalli SNCVL, Krishna G Rama, Sarma Pranjal, Mukhopadhyay Debasmita, Kamal Ahmed, Bhadra Utpal, Bhadra Manika Pal
Primary Institution: Indian Institute of Chemical Technology
Hypothesis
Chalcone-imidazolone conjugates induce apoptosis through a DNA damage pathway by affecting telomeres.
Conclusion
Chalcone-imidazolone conjugates cause significant DNA damage activity, leading to apoptosis and growth arrest in breast cancer cells.
Supporting Evidence
- Chalcone-imidazolone compounds caused upregulation of pro-apoptotic proteins in treated cells.
- DNA fragmentation was more prominent in compound-treated cells compared to controls.
- Telomerase activity was downregulated in cells treated with chalcone-imidazolone compounds.
Takeaway
The study found that certain compounds can make cancer cells die by damaging their DNA, which is like breaking their toys so they can't play anymore.
Methodology
The study involved treating MCF-7 breast cancer cells with chalcone-imidazolone compounds and analyzing apoptosis through various assays including TUNEL and Western blotting.
Participant Demographics
MCF-7 breast cancer cell line used in the study.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website